We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report CIS - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

CIS - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

CIS: Vaccine Market 2024

Vaccine Market Size in CIS

In 2022, the CIS vaccine market decreased by -21.7% to $X for the first time since 2019, thus ending a two-year rising trend. In general, consumption continues to indicate a temperate increase. As a result, consumption reached the peak level of $X. From 2019 to 2022, the growth of the market remained at a lower figure.

Vaccine Production in CIS

In value terms, vaccine production dropped to $X in 2022 estimated in export price. Over the period under review, production saw a strong increase. The most prominent rate of growth was recorded in 2016 when the production volume increased by 65%. Over the period under review, production hit record highs at $X in 2021, and then dropped in the following year.

Vaccine Exports

Exports in CIS

For the fourth year in a row, the CIS recorded growth in overseas shipments of vaccines for human medicine, which increased by 22% to X tons in 2022. In general, exports showed a remarkable increase. The most prominent rate of growth was recorded in 2017 when exports increased by 79% against the previous year. The volume of export peaked in 2022 and is likely to see steady growth in the near future.

In value terms, vaccine exports fell to $X in 2022. Overall, exports recorded a remarkable increase. The pace of growth appeared the most rapid in 2017 with an increase of 57%. Over the period under review, the exports reached the maximum at $X in 2021, and then reduced in the following year.

Exports by Country

The shipments of the one major exporters of vaccines for human medicine, namely Russia, represented more than two-thirds of total export.

Russia was also the fastest-growing in terms of the vaccines for human medicine exports, with a CAGR of +14.2% from 2012 to 2022. From 2012 to 2022, the share of Russia increased by +21 percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) also remains the largest vaccine supplier in the CIS.

From 2012 to 2022, the average annual rate of growth in terms of value in Russia amounted to +12.9%.

Export Prices by Country

The export price in the CIS stood at $X per ton in 2022, which is down by -25% against the previous year. In general, the export price saw a relatively flat trend pattern. The pace of growth appeared the most rapid in 2013 when the export price increased by 18%. The level of export peaked at $X per ton in 2021, and then contracted rapidly in the following year.

As there is only one major export destination, the average price level is determined by prices for Russia.

From 2012 to 2022, the rate of growth in terms of prices for Russia amounted to -1.1% per year.

Vaccine Imports

Imports in CIS

Vaccine imports reduced sharply to X tons in 2022, waning by -29.7% compared with the previous year's figure. Total imports indicated a mild increase from 2012 to 2022: its volume increased at an average annual rate of +1.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +17.7% against 2020 indices. The growth pace was the most rapid in 2021 with an increase of 67%. As a result, imports reached the peak of X tons, and then declined rapidly in the following year.

In value terms, vaccine imports fell notably to $X in 2022. Overall, imports, however, showed strong growth. The pace of growth appeared the most rapid in 2021 with an increase of 138% against the previous year. As a result, imports reached the peak of $X, and then dropped dramatically in the following year.

Imports by Country

Russia (X tons) and Kazakhstan (X tons) represented roughly 57% of total imports in 2022. Uzbekistan (X tons) ranks next in terms of the total imports with a 13% share, followed by Belarus (11%), Tajikistan (8.2%) and Kyrgyzstan (5.2%). Azerbaijan (X tons) and Armenia (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Tajikistan (with a CAGR of +11.7%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) constitutes the largest market for imported vaccines for human medicine in the CIS, comprising 47% of total imports. The second position in the ranking was held by Kazakhstan ($X), with a 17% share of total imports. It was followed by Uzbekistan, with a 13% share.

From 2012 to 2022, the average annual rate of growth in terms of value in Russia totaled +7.4%. In the other countries, the average annual rates were as follows: Kazakhstan (+2.0% per year) and Uzbekistan (+22.5% per year).

Import Prices by Country

In 2022, the import price in the CIS amounted to $X per ton, which is down by -18.8% against the previous year. Overall, the import price, however, posted a prominent expansion. The pace of growth was the most pronounced in 2021 when the import price increased by 42%. As a result, import price reached the peak level of $X per ton, and then fell sharply in the following year.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Russia ($X per ton), while Kyrgyzstan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Tajikistan (+11.5%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The country with the largest volume of vaccines consumption was Russia, accounting for 93% of total volume. It was followed by Kazakhstan, with a 2.3% share of total consumption.
Russia remains the largest vaccines producing country in the CIS, accounting for 99% of total volume.
In value terms, Russia remains the largest vaccines supplier in the CIS.
In value terms, Russia constitutes the largest market for imported vaccines for human medicine in the CIS, comprising 55% of total imports. The second position in the ranking was occupied by Kazakhstan, with a 22% share of total imports. It was followed by Uzbekistan, with a 11% share.
In 2020, the vaccines export price in the CIS amounted to $356,719 per ton, reducing by -8.6% against the previous year.
In 2020, the vaccines import price in the CIS amounted to $621,476 per ton, reducing by -12% against the previous year.

This report provides an in-depth analysis of the vaccine market in CIS. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in CIS, split by region and country
  • Trade (exports and imports) in CIS
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Armenia
    • Azerbaijan
    • Belarus
    • Kazakhstan
    • Kyrgyzstan
    • Moldova
    • Russia
    • Tajikistan
    • Uzbekistan

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 382

This report provides an in-depth analysis of the vaccine market in Asia.

U.S. - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 459

This report provides an in-depth analysis of the vaccine market in the U.S..

China - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 423

This report provides an in-depth analysis of the vaccine market in China.

EU - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 439

This report provides an in-depth analysis of the vaccine market in the EU.

World - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 2583

This report provides an in-depth analysis of the global vaccine market.

Free Data: Vaccines For Human Medicine - CIS
Table
Vaccines For Human Medicine - CIS - Table
Dashboard
Vaccines For Human Medicine - CIS - Dashboard
Report
Vaccines For Human Medicine - CIS - Report